Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy.

Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy.

Item
http://www.wikidata.org/entity/Q39893146
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesEnhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.Uptake and intracellular trafficking of superantigens in dendritic cells.Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacyMurine CD4+ T cell responses are inhibited by cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer.Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cells.Antigen targeting to major histocompatibility complex class II with streptococcal mitogenic exotoxin Z-2 M1, a superantigen-based vaccine carrierTargeting Dendritic Cells in vivo for Cancer Therapy.Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.Targeting skin dendritic cells to improve intradermal vaccination.CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic.Designing injectable, covalently cross-linked hydrogels for biomedical applications.Developments and recent advancements in the field of endogenous amino acid selective bond forming reactions for bioconjugation.Immunological low-dose radiation modulates the pediatric medulloblastoma antigens and enhances antibody-dependent cellular cytotoxicity.Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.
P2860

Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy.

Item
http://www.wikidata.org/entity/Q39893146
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@en
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@nl
type
label
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@en
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@nl
prefLabel
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@en
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Targeting antigen to MHC class ...... on and enhances immunotherapy.
@en
P2093
P304
P31
P356
10.4049/JIMMUNOL.182.3.1260
P407
P433
P478
P50
P577
P5875
P698
P921